Payers

Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.

Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test

Triglycerides are back in the spotlight. Europe is reviewing Sobi’s olezarsen for severe risk.

Kenya Moves to Keep Cancer From Bankrupting Families

Germany Is Paying the Price for Leaving Tardive Dyskinesia Behind

Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?

MASH, a serious fatty liver disease, is becoming a cardiometabolic condition
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
